Barclays’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.24M Sell
50,396
-82,797
-62% -$6.01M ﹤0.01% 1920
2025
Q4
$10.1M Sell
133,193
-509,123
-79% -$32.1M ﹤0.01% 1668
2025
Q3
$25.5M Buy
642,316
+33,494
+6% +$1.28M 0.01% 1089
2025
Q2
$26.4M Buy
608,822
+110,197
+22% +$4.19M 0.01% 977
2025
Q1
$18.6M Buy
498,625
+21,865
+5% +$845K 0.01% 1073
2024
Q4
$21.6M Buy
476,760
+111,714
+31% +$5.7M 0.01% 1078
2024
Q3
$21.4M Buy
365,046
+287,243
+369% +$13.8M 0.01% 1033
2024
Q2
$3.06M Buy
77,803
+41,157
+112% +$2M ﹤0.01% 1845
2024
Q1
$2.44M Buy
36,646
+2,590
+8% +$113K ﹤0.01% 2410
2023
Q4
$952K Buy
+34,056
New +$683K ﹤0.01% 3466

Other funds holding APGE